(Q51591530)

7 April 2018

title

Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients. (English)

1 reference

7 April 2018

author name string

C Thürig

1

1 reference

7 April 2018

L Böhlen

2

1 reference

7 April 2018

M Schneider

3

1 reference

7 April 2018

M de Courten

4

1 reference

7 April 2018

S G Shaw

5

1 reference

7 April 2018

W Riesen

6

1 reference

7 April 2018

P Weidmann

7

1 reference

7 April 2018

publication date

1 January 1995

1 reference

7 April 2018

European Journal of Clinical Pharmacology

published in

1 reference

7 April 2018

volume

49

1 reference

7 April 2018

issue

1-2

1 reference

7 April 2018

page(s)

21-26

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/bf00192353

exact match

0 references

cites work

Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents.

1 reference

12 December 2020

ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients

1 reference

12 December 2020

Metabolic effects of enalapril and nifedipine in diabetic hypertensives

1 reference

12 December 2020

Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects

1 reference

12 December 2020

Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension

1 reference

12 December 2020

Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension

1 reference

12 December 2020

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

1 reference

12 December 2020

Improved glucose regulation and microalbuminuria/proteinuria in diabetic patients treated with ACE inhibitors. A meta-analysis of published studies of 1985-1990

1 reference

12 December 2020

Epidemiology of coronary heart disease: the Framingham study.

1 reference

12 December 2020

Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.

1 reference

12 December 2020

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

1 reference

12 December 2020

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

12 December 2020

Plasma glucose and insulin profiles in normal subjects ingesting diets of varying carbohydrate, fat, and protein content

1 reference

12 December 2020

Modified protocols improve insulin sensitivity estimation using the minimal model

1 reference

12 December 2020

Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study

1 reference

12 December 2020

Glucose and Lipid Metabolism During Long-Term Treatment with Cilazapril in Hypertensive Patients With or Without Impaired Glucose Metabolism

1 reference

12 December 2020

Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Carbohydrate metabolism in hypertension: influence of treatment

1 reference

12 December 2020

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

12 December 2020

Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor.

1 reference

12 December 2020

Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril.

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Insulin resistance, hyperinsulinemia and hypertension.

1 reference

12 December 2020

ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

1 reference

12 December 2020

Determination of the anaerobic threshold by a noninvasive field test in runners

1 reference

12 December 2020

Insulin resistance in essential hypertension

1 reference

12 December 2020

Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Exercise and hypertension. Maximizing the benefits in patients receiving drug therapy

1 reference

12 December 2020

Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.

1 reference

12 December 2020

Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus.

1 reference

12 December 2020

The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension

1 reference

12 December 2020

Insulin resistance and risk factors for coronary heart disease

1 reference

12 December 2020

Antihypertensive agents, serum lipoproteins and glucose metabolism

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00192353

1 reference

7 April 2018

1 reference

7 April 2018